These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3545549)

  • 1. FLow cytometry quantitation of peripheral blood T-cell subsets as a monitor of renal allograft rejection.
    Binkley WF; Valenzuela R; Braun WE; Doedhar SD; Novick AC; Steinmuller DR; Williams G
    Cleve Clin Q; 1986; 53(3):249-56. PubMed ID: 3545549
    [No Abstract]   [Full Text] [Related]  

  • 2. Flow-cytometric monitoring of ATG therapy for steroid-resistant rejection.
    Clark KR; Forsythe JL; Shenton BK; Lennard TW; Proud G; Taylor RM
    Transplant Proc; 1992 Feb; 24(1):315. PubMed ID: 1531714
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of monoclonal antibodies to T cells (OKT3) for treatment of acute cellular rejection after renal transplantation.
    Birkeland SA; Svendsen V; Rohr N; Hansen BL; Elbirk A; Foged N; Køhler F
    Transplant Proc; 1988 Jun; 20(3):451-4. PubMed ID: 3289183
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of rabbit antithymocyte serum (RATS) and OKT3 on peripheral blood mononuclear cell subsets following renal transplantation.
    Zaltzman JS; Cole EH; Freedman J
    Clin Transplant; 1994 Dec; 8(6):516-22. PubMed ID: 7865912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between two-color flow cytometry quantitation of activated T cells and acute allograft rejection.
    Hayes JM; Valenzuela R; Novick AC; Steinmuller DR; Williams G
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1605-8. PubMed ID: 3493570
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoclonal antibodies for kidney allograft rejection.
    Med Lett Drugs Ther; 1986 Oct; 28(724):97-8. PubMed ID: 3531791
    [No Abstract]   [Full Text] [Related]  

  • 7. Inducible IL-2 on CD8 lymphocytes as a postoperative predictor of rejection in renal allograft recipients.
    Langley J; Dickerman R; Vergne-Marini P; Williams J; Jensik S; Kenyon N; Anderson J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):939-43. PubMed ID: 8442275
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts.
    Soulillou JP; Cantarovich D; Le Mauff B; Giral M; Robillard N; Hourmant M; Hirn M; Jacques Y
    N Engl J Med; 1990 Apr; 322(17):1175-82. PubMed ID: 2157982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superior renal allograft survival and decreased rejection with early high-dose and sequential multi-species antilymphocyte globulin therapy.
    Thomas F; Cunningham P; Thomas J; Gross U; Gaskins D; Sash C; Parker K
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1874-8. PubMed ID: 3547892
    [No Abstract]   [Full Text] [Related]  

  • 10. Contribution of T-cell subset monitoring of renal transplant recipients in the cyclosporine era.
    Khanuja PS; Toledo-Pereyra LH; Gordon DA; Bandlien KO; Whitten JI
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1852-3. PubMed ID: 2652602
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunologic monitoring of antithymocyte globulin treatment for acute allograft rejection.
    Delmonico FL; Nelson PW; Colvin RB; Cosimi AB
    Transplant Proc; 1984 Dec; 16(6):1492-3. PubMed ID: 6390852
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro and in vivo human T cell repertoire in kidney allograft rejection.
    Finn OJ; Miceli MC; Sanfilippo A; Bollinger RR; Barry TS
    Transplant Proc; 1988 Apr; 20(2):155-8. PubMed ID: 3284032
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts.
    Cosimi AB; Colvin RB; Burton RC; Rubin RH; Goldstein G; Kung PC; Hansen WP; Delmonico FL; Russell PS
    N Engl J Med; 1981 Aug; 305(6):308-14. PubMed ID: 6454075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevant targets for therapy with monoclonal antibodies in allograft transplantation.
    Soulillou JP
    Kidney Int; 1994 Aug; 46(2):540-53. PubMed ID: 7967369
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of multiple rejection episodes with ALG or ATGAM after cadaveric renal transplantation.
    Toledo-Pereya LH; Whitten J; Baskin S; McNichol L; Thavarajah K; Lin W
    Bol Asoc Med P R; 1984 Jul; 76(7):293-6. PubMed ID: 6383417
    [No Abstract]   [Full Text] [Related]  

  • 16. Semi-specific immunosuppression in canine kidney allograft with I131 labelled ATG.
    Corman J; Smeesters C; Giroux L; St-Louis G; Leveille M; Lavigne CM; Lamoureux J; Jean G; Daloze P
    Transplant Proc; 1982 Dec; 14(4):656-8. PubMed ID: 6188256
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of association of human renal allograft rejection and circulating K-cell, NK-cell, or total T-cell levels.
    Ellis TM; Berry CR; Mendez-Picon G; Goldman MH; Lee HM; Mohanakumar T
    Clin Immunol Immunopathol; 1982 Dec; 25(3):335-47. PubMed ID: 6761023
    [No Abstract]   [Full Text] [Related]  

  • 18. New approaches to the use of antibodies for immunosuppression.
    Russell PS
    Transplant Proc; 1982 Sep; 14(3):506-8. PubMed ID: 6758236
    [No Abstract]   [Full Text] [Related]  

  • 19. Monitoring of ATG therapy by flow cytometry and lymphocyte counts in renal transplantation.
    Buchler M; Thibault G; al Najjar A; Valentin JF; Guerraoui A; Nivet H; Bardos P; Lebranchu Y
    Transplant Proc; 1996 Oct; 28(5):2817-8. PubMed ID: 8908076
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation with clinical types and lymphocyte subsets in chronic renal allograft rejection.
    Tanabe K; Toma H; Takahashi K; Teraoka S; Ota K
    Nihon Jinzo Gakkai Shi; 1986 Sep; 28(9):1285-91. PubMed ID: 3546879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.